Navigation Links
Remicade in Medical News

Driven by Sales of Enbrel, Remicade and Humira, spondyloarthropathies Drug Market Grew to Nearly $2 Billion in 2008

Newly Approved Simponi is Expected to Achieve Strong Uptake in this Niche Market, According to a New Report from Decision Resources WALTHAM, Mass., April 30 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, fin...

For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission

Abbott/Eisai's Humira Will Earn Decision Resources' Clinical Gold Standard Status for Ulcerative Colitis in 2012, According to a New Report from Decision Resources WALTHAM, Mass., April 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceu...

Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease

Humira Will Retain its Status as Decision Resources' Clinical Gold Standard for Crohn's Disease Through 2017, According to a New Report from Decision Resources WALTHAM, Mass., Jan. 26, /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceuti...

Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohn's Disease

Oral 5-Aminosalicylates Will Continue to be Used in Early Lines of Therapy, According to a New Report from Decision Resources WALTHAM, Mass., Oct. 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, f...

A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market

Ustekinumab Will Earn a 5.4 Percent Patient Share by 2012, According to a New Report from Decision Resources WALTHAM, Mass., June 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, fin...

Although Remicade and Humira Are Being Increasingly Prescribed for Crohn's Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies

Nearly One-Third of Surveyed Managed Care Organizations Levy Coinsurance Charges and Other Protocols on Remicade and Humira, According to a New Report from Decision Resources WALTHAM, Mass., March 4 /PRNewswire/ -- Decision Resources, one of the world's leading research ...

U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic

...Control Offers Opportunities for Differentiation , Centocor Ortho Biotech's remicade and Abbott's Humira stand to most directly benefit from this strategy as th...ogic, therapeutic area tenders may help some brands remain competitive with remicade and Humira," said Michael Malecki, Ph.D., product manager for Formulary For...

Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA

... Agency strengthens 'black box' warning on medicines such as Enbrel, remicade TUESDAY, Aug. 4 (HealthDay News) -- Drugs widely used to fight ... inflammation and damage to bones, cartilage and other tissue. They include remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizuma...

Brazil's Rheumatoid Arthritis Drug Market Will Grow $115 Million by 2013

...e than $315 million in 2013. The 2008 market leaders were the tumor necrosis factor-alpha (TNF-alpha) inhibitors Abbott's Humira and Schering-Plough's remicade which recorded sales of $50 million and $43 million, respectively, despite a combined patient share of two percent. Wyeth's Enbrel, the third marketed...

Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit

...ical benefit to a pharmacy benefit by 2014, citing Centocor Ortho Biotech's remicade and UCB's Cimzia among products that will be most affected by this shift. A...utlays--in part due to physicians preferentially prescribing agents such as remicade so the physician can purchase the agent at a discount relative to the reimb...
Remicade in Medical Technology

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... First-of-its-Kind Study Demonstrates remicade More Likely to Maintain Steroid-Free Remission in ...ed that a greater proportion of patients receiving remicade (infliximab) maintained steroid-free remission at ...nvestigator. "The data further support the use of remicade earlier in the treatment of moderate to severe Cro...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... Data from SONIC Trial Showed remicade Therapy is More Likely to Induce Steroid-Free Re... that at week 26, 57 percent of patients receiving remicade combination therapy and 44 percent of patients receiving remicade monotherapy achieved steroid-free remission, the p...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

...eported at weeks 8 and 30 among patients receiving remicade and meeting the disease duration criteria. These f... "These data are encouraging because we see that remicade is an effective treatment option for patients with...Regardless of disease duration, patients receiving remicade showed significant improvements in clinical respon...

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

...y 1,500 subjects, 71 percent of patients receiving remicade 3 mg/kg and 79 percent of patients receiving remicade 5 mg/kg achieved a PASI 75, or at least a 75 perce...y, 39 percent and 52 percent of patients receiving remicade 3 mg/kg and 5 mg/kg, respectively, achieved a PASI...

Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up

... "The data demonstrate the sustained efficacy of remicade for many patients with UC," said co-principle inve...=364). The 728 patients were randomized to receive remicade 5 mg/kg, remicade 10 mg/kg or placebo at weeks 0, 2, 6 and every sub...

Remicade Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation

...resonance imaging (MRI). The recommended dose of remicade in AS is 5 mg/kg given as an IV induction regimen ...were analyzed to determine the long-term effect of remicade on spinal mobility. The double-blind extension of ...ASMI and chest expansion scores as patients in the remicade group at weeks 54, 78 and 102. "Ankylosing spond...
Remicade in Medical Products

AHFS Patient Drug Information

Features:...pliance. Empower patients to be more active and involved in their treatment. New and updated drug information includes: Pepcid, Flonase, Paxil, remicade With Skyscape's patented smARTlink™ technology, FamilyRx™ can easily cross-index with other titles from Skyscape to provide a powerful a...
Company:Skyscape, Inc.
Remicade in Biological News

Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients

PHILADELPHIA, PA, October 15, 2007- Clinical data presented today at the annual meeting of the American College of Gastroenterology (ACG) show that REMICADE significantly reduces the incidence of colectomy surgeries for patients with moderately to severely active ulcerative colitis (UC). Accordin...
Remicade in Biological Technology

Schering-Plough Reports Financial Results for 2009 Second Quarter

...ion. "Our diverse product strength - from remicade to TEMODAR to NUVARING to MIRALAX - and our rich g... foreign exchange of 10 percent. Sales of remicade increased 2 percent (19 percent operational growth...d quarter of 2009 due to continued market growth. remicade is a treatment for inflammatory diseases that Sche...

CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market

...s sold in the US. The top 5 leading biotech drugs sold in the USA are Enbrel (Amgen, Wyeth), Aranesp (Amgen), Rituxan (Biogen Idec, Genentech, Roche), remicade (Johnson & Johnson, Schering-Plough) and Procrit (Johnson and Johnson). According to CBDMT®, contract biomanufacturing is a significant ma...

Schering-Plough Reports Financial Results for First Quarter of 2008

...ated to Organon, the OBS human health business acquired in 2007. Sales of remicade increased 36 percent to $507 million in the first quarter of 2008 due to co...HUMAN PRESCRIPTION PHARMACEUTICALS a/ $3,557 $2,398 48% remicade 507 373 36% NASONEX ...

Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report

...e most promising candidates." Drugs/Companies mentioned in this report: allopurinol; febuxostat (Teijin/Ipsen/TAP); Puricase (pegloticase; Savient); remicade (infliximab; Centocor/Schering-Plough/Essex), Enbrel (etanercept; Wyeth/Amgen); Humira (adalimumab; Abbott), Orencia (abatacept; Bristol-Myers Squibb)...

Centocor/Janssen-Cilag's Ustekinumab Will Become the Gold Standard for Psoriasis By 2011

...numab will achieve gold standard status because of its competitive advantages in long-term efficacy over Centocor/Schering- Plough/Mitsubishi Tanabe's remicade and due to its superior effect on plaque clearance when compared to Amgen/Wyeth/Takeda's Enbrel. According to the new report entitled Psoriasis: Ust...

Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year

...Organon, the OBS human health business. Sales of remicade increased 35 percent to $455 million in the fourth...market growth and expanded use across indications. remicade is a treatment for inflammatory diseases that Sche...nt, commercialization and distribution of both remicade (infliximab) and golimumab. (Announced Dec. 21, 2...

REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide

...sis factor (TNF)-alpha therapy worldwide. In fact, remicade has been used to treat more patients worldwide than all other anti-TNF-alpha agents combined. remicade was the first anti-TNF-alpha treatment approved by...early impossible. It's hard to put into words what remicade has meant to me." Through a long line of firsts i...
Other Tags
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... ... by High Times magazine. What are the STASH awards? The Significant Technological ... made by the cannabis-cultivation community as well as tried-and-true products that have stood ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, ... on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. ... this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only Thermage ... also the first provider of Exilis non-surgical fat reduction in New York. Due ... attracted a large International clientele. Many patients travel to New York to get ...
(Date:7/31/2015)... ... 2015 , ... The 2nd annual Ride to Fight On will start and ... 2015. The Ride to Fight On is a cycling fundraiser that benefits the West ... Clinic and The University of Tennessee Health Science Center. A health and wellness festival ...
(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based drug ... new True North Conference Center. The medical community, social workers, law enforcement, and ... be more aligned in the effort to better understand and combat sex trafficking. ...
Breaking Medicine News(10 mins):Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3
(Date:7/23/2015)... July 23, 2015 Research and Markets ... the "Global Outlook of the Biometrics Industry ... The global biometrics market is likely ... commercial applications owing to the uptake of multiple ... transformation that enhances the growth of biometrics in ...
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
Other Contents